Literature DB >> 9271339

Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.

V J Watts1, K A Neve.   

Abstract

The D2-like dopamine receptors couple to a variety of signal transduction pathways, including inhibition of adenylate cyclase, mitogenesis, and activation of potassium channels. Although these effects are mediated via pertussis toxin-sensitive G proteins, G(i/o), it is likely that some of these effects are influenced by the release of G protein betagamma subunits. Type II adenylate cyclase (ACII) is highly regulated by multiple biochemical stimuli, including protein kinase C, forskolin, G protein alpha subunits, and G protein betagamma subunits. The ability of betagamma subunits to activate this enzyme in the presence of activated alpha(s) has been particularly well characterized. Although stimulation by betagamma subunits has been described as conditional on the presence of activated alpha(s), betagamma subunits also potentiate ACII activity after activation of protein kinase C. We created stable cell lines expressing ACII and the D2L receptor, the D3 receptor, or the D4.4 receptor. Activation of D2L or D4.4 receptors, but not D3 receptors, potentiated beta-adrenergic receptor/Gs-stimulated activity of ACII, as measured by the intracellular accumulation of cAMP. Similarly, stimulation of D2L or D4.4 receptors potentiated phorbol ester-stimulated ACII activity in the absence of activated alpha(s), whereas stimulation of D3 receptors did not. The effect of D2-like receptor stimulation was blocked by pretreatment with pertussis toxin and by inhibition of protein kinase C. We propose that activation of both D2L and D4.4 dopamine receptors potentiated phorbol-12-myristate-13-acetate-stimulated ACII activity through the release of betagamma subunits from pertussis toxin-sensitive G proteins. In contrast, the lack of D3 receptor-mediated effects suggests that stimulation of D3 receptors does not result in an appreciable release of betagamma subunits.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271339     DOI: 10.1124/mol.52.2.181

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  17 in total

1.  Activation of the D4 dopamine receptor attenuates proliferation and migration of vascular smooth muscle cells through downregulation of AT1a receptor expression.

Authors:  Changqing Yu; Jianghua Chen; Weiwei Guan; Yu Han; Wei Eric Wang; Xukai Wang; Hongyong Wang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

2.  Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats.

Authors:  Rakesh Kumar; Lindsay R Riddle; Suzy A Griffin; Wenhua Chu; Suwanna Vangveravong; Janet Neisewander; Robert H Mach; Robert R Luedtke
Journal:  Neuropharmacology       Date:  2009-02-05       Impact factor: 5.250

3.  A dopamine D2 receptor mutant capable of G protein-mediated signaling but deficient in arrestin binding.

Authors:  Hongxiang Lan; Yong Liu; Michal I Bell; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-22       Impact factor: 4.436

4.  Bias analyses of preclinical and clinical D2 dopamine ligands: studies with immediate and complex signaling pathways.

Authors:  Tarsis F Brust; Michael P Hayes; David L Roman; Kevin D Burris; Val J Watts
Journal:  J Pharmacol Exp Ther       Date:  2014-12-24       Impact factor: 4.030

5.  Cooperative activation of D1 and D2 dopamine receptors enhances a hyperpolarization-activated inward current in layer I interneurons.

Authors:  JianPing Wu; John J Hablitz
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

6.  The dopamine D(2) receptor is expressed and sensitizes adenylyl cyclase activity in airway smooth muscle.

Authors:  Kentaro Mizuta; Yi Zhang; Dingbang Xu; Eiji Masaki; Reynold A Panettieri; Charles W Emala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

7.  K+ channel modulation in rodent neurohypophysial nerve terminals by sigma receptors and not by dopamine receptors.

Authors:  R A Wilke; P J Lupardus; D K Grandy; M Rubinstein; M J Low; M B Jackson
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

8.  New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling.

Authors:  Tarsis F Brust; Michael P Hayes; David L Roman; Val J Watts
Journal:  Biochem Pharmacol       Date:  2014-11-07       Impact factor: 5.858

9.  Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.

Authors:  V J Watts; B L Wiens; M G Cumbay; M N Vu; R L Neve; K A Neve
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

10.  Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers.

Authors:  Lina Yao; Peidong Fan; Zhan Jiang; William S Mailliard; Adrienne S Gordon; Ivan Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.